A Dual‐Enzyme Delivery System Targeting Lactate Depletion to Induce Disulfidptosis and Activate STING Pathway for Inhibiting Breast Cancer Metastasis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Lianxiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, Shandong Provincial Key laboratory of Glycoscience and Glycotherapeutics, School of Medicine a…. Hauptthemen laut MEDLINE: Lactic Acid, Breast Neoplasms, Disulfidptosis, Glucose Oxidase. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Major Scientific and Technological Innovation Project of Shandong Province, Shandong Provincial Natural Science Foundation, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Lactate, as a key metabolite in the tumor microenvironment (TME), has been reported to inhibit the stimulator of interferon genes (STING) pathway and contribute to immunosuppression and tumor progression. Here, we develop a dual‐enzyme delivery system (Fuc@ZIF‐GOx‐LOx, FZGL) that is coated with fucoidan (Fuc) and loaded with glucose oxidase (GOx) and lactate oxidase (LOx) based on zinc imidazolate framework‐90 (ZIF‐90), to inhibit breast cancer metastasis by “source interception and downstream blockade” of lactate. FZGL targets tumor cells via Fuc and releases GOx and LOx by the ATP‐responsive degradation of ZIF‐90. GOx rapidly consumes glucose to block lactate generation from the source (“source interception”) and induces disulfidptosis in tumor cells. LOx degrades accumulated lactate (“downstream blockade”) to alleviate immunosuppression. FZGL activates the cGAS‐STING pathway by damaging mitochondria and inducing mitochondrial DNA (mtDNA) release. Furthermore, lactate depletion can relieve lactate‐mediated inhibition of STING signaling, thereby enhancing the anti‐tumor immune response. In vivo experiments demonstrate that FZGL significantly promotes T cell infiltration and M1 macrophage polarization, and effectively inhibits the growth and lung metastasis of breast cancer. Our study provides a new approach for metastatic breast cancer treatment through lactate metabolism intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Ministry of Education, Shandong Provincial Key laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
- Laboratory For Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, China.
ORCID-Profile: Lianxiao Zhang, Jianhui Yang, Yanguo Su, Rui Chen, Tianze Jiang, Xia Zhao
Förderung
- Major Scientific and Technological Innovation Project of Shandong Province
- Shandong Provincial Natural Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, L., Yang, J., Pang, J., Diao, Q., Su, Y., Chen, R., Jiang, T., & Zhao, X. (2026). A Dual‐Enzyme Delivery System Targeting Lactate Depletion to Induce Disulfidptosis and Activate STING Pathway for Inhibiting Breast Cancer Metastasis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71801
Vancouver
Zhang L, Yang J, Pang J, Diao Q, Su Y, Chen R, et al. A Dual‐Enzyme Delivery System Targeting Lactate Depletion to Induce Disulfidptosis and Activate STING Pathway for Inhibiting Breast Cancer Metastasis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71801
BibTeX
@article{Zhang2026,
author = {Zhang, Lianxiao and Yang, Jianhui and Pang, Jinli and Diao, Qijie and Su, Yanguo and Chen, Rui and Jiang, Tianze and Zhao, Xia},
title = {A Dual‐Enzyme Delivery System Targeting Lactate Depletion to Induce Disulfidptosis and Activate STING Pathway for Inhibiting Breast Cancer Metastasis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71801}
}
EUVIMED